Wells Fargo Downgrades Nuveen Churchill Direct to Underweight, Lowers Price Target to $12

Benzinga Newsdesk www.benzinga.com Negative 92.3%

Neg 92.3% Neu 0% Pos 0%

Wells Fargo analyst Finian O'Shea downgrades Nuveen Churchill Direct (NYSE:NCDL) from Equal-Weight to Underweight and lowers the price target from $13 to $12.